Association of Tramadol-Induced Ovarian Damage and Reproductive Dysfunction with Adenosine Triphosphate and the

Neset Gumusburun1, Ilhan Bahri Delibasi1, Seval Bulut2

  • 1Department of Gynecology and Obstetrics, Medical Park Tokat Hospital, Tokat 60030, Türkiye.

PubMed

Insights

Adenosine triphosphate (ATP) protects against tramadol-induced ovarian damage and infertility in rats. This study demonstrates ATP

Area of Science:

  • Reproductive Toxicology
  • Biochemistry

Background:

  • Tramadol, a weak opioid analgesic, is known to cause ovarian damage.
  • Oxidative stress is implicated in tramadol's adverse effects on female reproduction.

Purpose of the Study:

  • To investigate the protective effects of adenosine triphosphate (ATP) against tramadol-induced ovarian damage and reproductive dysfunction in a rat model.

Main Methods:

  • Rats were divided into four groups: healthy, ATP only, tramadol only, and ATP + tramadol.
  • Treatments were administered daily for 14 days.
  • Ovarian tissue was analyzed for biochemical markers, histology, and immunohistochemistry. Reproductive outcomes including fertility and pregnancy were assessed.

Main Results:

  • Tramadol increased oxidative stress markers (malondialdehyde) and inflammation (interleukin-6) while decreasing antioxidant levels (glutathione, superoxide dismutase, catalase).
  • Tramadol disrupted ovarian histology and induced infertility and delayed pregnancy.
  • ATP treatment significantly ameliorated tramadol-induced biochemical, histological, and reproductive impairments.

Conclusions:

  • ATP effectively suppressed tramadol-induced oxidative and inflammatory ovarian injury.
  • ATP mitigated tramadol's negative impact on fertility and pregnancy outcomes in rats.
  • ATP demonstrated protective effects against tramadol-induced reproductive toxicity.